Discovery of TAS3351, a brain-penetrable fourth-generation EGFR-TKI that overcomes T790M and C797S resistance mutations
Hidefumi Kasuga(Taiho Pharmaceutical (Japan)), Shinji Mizuarai(Food Research Institute)
Cited by 0
Related Papers
Inhibition of p70S6K2 down-regulates Hedgehog/GLI pathway in non-small cell lung cancer cell lines
|Molecular Cancer|2009|45